• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

调节性 T 细胞衍生的 TRAIL 对于外周耐受不是必需的。

Regulatory T Cell-Derived TRAIL Is Not Required for Peripheral Tolerance.

机构信息

Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261.

Tumor Microenvironment Center, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA 15232.

出版信息

Immunohorizons. 2021 Jan 22;5(1):48-58. doi: 10.4049/immunohorizons.2000098.

DOI:10.4049/immunohorizons.2000098
PMID:33483333
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8663370/
Abstract

TRAIL (/TRAIL/CD253/Apo2L) is an important immune molecule that mediates apoptosis. TRAIL can play key roles in regulating cell death in the tumor and autoimmune microenvironments. However, dissecting TRAIL function remains difficult because of the lack of optimal models. We have now generated a conditional knockout ( ) for cell type-specific analysis of TRAIL function on C57BL/6, BALB/c, and NOD backgrounds. Previous studies have suggested a role for TRAIL in regulatory T cell (T)-mediated suppression. We generated mice with a T-restricted deletion and surprisingly found no impact on tumor growth in C57BL/6 and BALB/c tumor models. Furthermore, we found no difference in the suppressive capacity of -deficient T and no change in function or proliferation of T cells in tumors. We also assessed the role of TRAIL on T in two autoimmune mouse models: the NOD mouse model of autoimmune diabetes and the myelin oligodendrocyte glycoprotein (MOG) C57BL/6 model of experimental autoimmune encephalomyelitis. We found that deletion of on T had no effect on disease progression in either model. We conclude that T do not appear to be dependent on TRAIL exclusively as a mechanism of suppression in both the tumor and autoimmune microenvironments, although it remains possible that TRAIL may contribute in combination with other mechanisms and/or in different disease settings. Our conditional knockout mouse should prove to be a useful tool for the dissection of TRAIL function on different cell populations in multiple mouse models of human disease.

摘要

TRAIL(/TRAIL/CD253/Apo2L)是一种重要的免疫分子,介导细胞凋亡。TRAIL 在肿瘤和自身免疫微环境中调节细胞死亡方面发挥着关键作用。然而,由于缺乏最佳模型,解析 TRAIL 功能仍然具有挑战性。我们现在已经生成了一种条件性敲除(),用于在 C57BL/6、BALB/c 和 NOD 背景下对 TRAIL 功能进行细胞类型特异性分析。先前的研究表明 TRAIL 在调节性 T 细胞(T 细胞)介导的抑制中发挥作用。我们生成了 T 细胞受限的缺失小鼠,令人惊讶的是,在 C57BL/6 和 BALB/c 肿瘤模型中,这对肿瘤生长没有影响。此外,我们没有发现 -缺陷 T 细胞的抑制能力有差异,也没有发现 T 细胞在肿瘤中的功能或增殖发生变化。我们还评估了 TRAIL 在两种自身免疫性小鼠模型中的作用:自身免疫性糖尿病的 NOD 小鼠模型和实验性自身免疫性脑脊髓炎的 MOG C57BL/6 模型。我们发现 T 细胞上的缺失对这两种模型中的疾病进展均无影响。我们得出结论,T 细胞似乎不依赖 TRAIL 作为其在肿瘤和自身免疫微环境中抑制的唯一机制,尽管 TRAIL 可能与其他机制结合或以不同的疾病状态发挥作用仍有可能。我们的条件性敲除小鼠应该证明是在多种人类疾病的小鼠模型中对不同细胞群体的 TRAIL 功能进行剖析的有用工具。

相似文献

1
Regulatory T Cell-Derived TRAIL Is Not Required for Peripheral Tolerance.调节性 T 细胞衍生的 TRAIL 对于外周耐受不是必需的。
Immunohorizons. 2021 Jan 22;5(1):48-58. doi: 10.4049/immunohorizons.2000098.
2
Dual effects of TRAIL in suppression of autoimmunity: the inhibition of Th1 cells and the promotion of regulatory T cells.TRAIL 在抑制自身免疫中的双重作用:抑制 Th1 细胞和促进调节性 T 细胞。
J Immunol. 2010 Nov 1;185(9):5259-67. doi: 10.4049/jimmunol.0902797. Epub 2010 Oct 4.
3
TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.TRAIL 介导的 T 细胞受体信号抑制可抑制实验性自身免疫性脑脊髓炎中的 T 细胞激活和炎症。
Front Immunol. 2018 Jan 22;9:15. doi: 10.3389/fimmu.2018.00015. eCollection 2018.
4
TNF-related apoptosis-inducing ligand (TRAIL)/Apo2L suppresses experimental autoimmune encephalomyelitis in mice.肿瘤坏死因子相关凋亡诱导配体(TRAIL)/Apo2L抑制小鼠实验性自身免疫性脑脊髓炎。
Immunol Cell Biol. 2005 Oct;83(5):511-9. doi: 10.1111/j.1440-1711.2005.01358.x.
5
Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.调节性T细胞参与表达髓鞘少突胶质细胞糖蛋白加TRAIL的树突状细胞对实验性自身免疫性脑脊髓炎的预防作用。
J Immunol. 2007 Jan 15;178(2):918-25. doi: 10.4049/jimmunol.178.2.918.
6
Prevention of experimental autoimmune encephalomyelitis by transfer of embryonic stem cell-derived dendritic cells expressing myelin oligodendrocyte glycoprotein peptide along with TRAIL or programmed death-1 ligand.通过转移表达髓鞘少突胶质细胞糖蛋白肽以及肿瘤坏死因子相关凋亡诱导配体(TRAIL)或程序性死亡-1配体的胚胎干细胞衍生树突状细胞预防实验性自身免疫性脑脊髓炎
J Immunol. 2005 Feb 15;174(4):1888-97. doi: 10.4049/jimmunol.174.4.1888.
7
A GM-CSF-neuroantigen tolerogenic vaccine elicits inefficient antigen recognition events below the CD40L triggering threshold to expand CD4 CD25 FOXP3 Tregs that inhibit experimental autoimmune encephalomyelitis (EAE).GM-CSF-神经抗原耐受疫苗引发低于 CD40L 触发阈值的低效抗原识别事件,以扩增抑制实验性自身免疫性脑脊髓炎(EAE)的 CD4 CD25 FOXP3 Treg。
J Neuroinflammation. 2020 Jun 10;17(1):180. doi: 10.1186/s12974-020-01856-8.
8
A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4 CD25 FOXP3 Regulatory T Cells in Myelin-Specific TCR Transgenic Mice Contingent Upon Low-Efficiency T Cell Antigen Receptor Recognition.GMCSF-神经抗原耐受疫苗在髓鞘特异性 TCR 转基因小鼠中诱导全身性 CD4 CD25 FOXP3 调节性 T 细胞淋巴细胞增多,这取决于低效率的 T 细胞抗原受体识别。
Front Immunol. 2019 Jan 10;9:3119. doi: 10.3389/fimmu.2018.03119. eCollection 2018.
9
Roles of TNF-related apoptosis-inducing ligand in experimental autoimmune encephalomyelitis.肿瘤坏死因子相关凋亡诱导配体在实验性自身免疫性脑脊髓炎中的作用
J Immunol. 2001 Jan 15;166(2):1314-9. doi: 10.4049/jimmunol.166.2.1314.
10
A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4 and CD8 T Cells.一种耐受原性人工 APC 通过直接和选择性调节髓鞘肽自身反应性 CD4 和 CD8 T 细胞,持久改善实验性自身免疫性脑脊髓炎。
J Immunol. 2018 Aug 15;201(4):1194-1210. doi: 10.4049/jimmunol.1800108. Epub 2018 Jul 9.

引用本文的文献

1
Characterization of Freshly Isolated Human Peripheral Blood B Cells, Monocytes, CD4+ and CD8+ T Cells, and Skin Mast Cells by Quantitative Transcriptomics.通过定量转录组学对新鲜分离的人外周血B细胞、单核细胞、CD4⁺和CD8⁺T细胞以及皮肤肥大细胞进行表征。
Int J Mol Sci. 2024 Dec 4;25(23):13050. doi: 10.3390/ijms252313050.
2
Blocking TRAIL-DR5 signaling pathway with soluble death receptor 5 fusion protein mitigates radiation-induced injury.用可溶性死亡受体5融合蛋白阻断TRAIL-DR5信号通路可减轻辐射诱导的损伤。
Front Pharmacol. 2023 May 18;14:1171293. doi: 10.3389/fphar.2023.1171293. eCollection 2023.
3
Repositioning the Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) on the TRAIL to the Development of Diabetes Mellitus: An Update of Experimental and Clinical Evidence.

本文引用的文献

1
T Regulatory Cells and Priming the Suppressive Tumor Microenvironment.调节性 T 细胞与抑制性肿瘤微环境的形成。
Front Immunol. 2019 Oct 15;10:2453. doi: 10.3389/fimmu.2019.02453. eCollection 2019.
2
The Role of TRAIL/DRs in the Modulation of Immune Cells and Responses.肿瘤坏死因子相关凋亡诱导配体/死亡受体在免疫细胞及免疫反应调节中的作用
Cancers (Basel). 2019 Sep 30;11(10):1469. doi: 10.3390/cancers11101469.
3
Antibodies and Derivatives Targeting DR4 and DR5 for Cancer Therapy.用于癌症治疗的靶向DR4和DR5的抗体及衍生物
重新定位肿瘤坏死因子相关凋亡诱导配体 (TRAIL) 在 TRAIL 致糖尿病发病机制中的作用:实验与临床证据的更新。
Int J Mol Sci. 2022 Mar 17;23(6):3225. doi: 10.3390/ijms23063225.
Antibodies (Basel). 2017 Oct 25;6(4):16. doi: 10.3390/antib6040016.
4
Treg Cells Promote the SREBP1-Dependent Metabolic Fitness of Tumor-Promoting Macrophages via Repression of CD8 T Cell-Derived Interferon-γ.调节性 T 细胞通过抑制 CD8 T 细胞衍生的干扰素-γ促进促肿瘤巨噬细胞的 SREBP1 依赖性代谢适应性。
Immunity. 2019 Aug 20;51(2):381-397.e6. doi: 10.1016/j.immuni.2019.06.017. Epub 2019 Jul 23.
5
TRAIL suppresses gut inflammation and inhibits colitogeic T-cell activation in experimental colitis via an apoptosis-independent pathway.TRAIL 通过一种不依赖凋亡的途径抑制实验性结肠炎中的肠道炎症并抑制致结肠炎 T 细胞的活化。
Mucosal Immunol. 2019 Jul;12(4):980-989. doi: 10.1038/s41385-019-0168-y. Epub 2019 May 11.
6
TRAIL and FasL Functions in Cancer and Autoimmune Diseases: Towards an Increasing Complexity.肿瘤坏死因子相关凋亡诱导配体(TRAIL)和Fas配体(FasL)在癌症和自身免疫性疾病中的作用:复杂性日益增加。
Cancers (Basel). 2019 May 8;11(5):639. doi: 10.3390/cancers11050639.
7
Importance of TRAIL Molecular Anatomy in Receptor Oligomerization and Signaling. Implications for Cancer Therapy.TRAIL分子结构在受体寡聚化和信号传导中的重要性。对癌症治疗的启示。
Cancers (Basel). 2019 Mar 29;11(4):444. doi: 10.3390/cancers11040444.
8
Regulatory T cells in cancer immunosuppression - implications for anticancer therapy.肿瘤免疫抑制中的调节性 T 细胞——对癌症治疗的影响。
Nat Rev Clin Oncol. 2019 Jun;16(6):356-371. doi: 10.1038/s41571-019-0175-7.
9
Identification and validation of a tumor-infiltrating Treg transcriptional signature conserved across species and tumor types.鉴定和验证跨物种和肿瘤类型的肿瘤浸润性 Treg 转录特征。
Proc Natl Acad Sci U S A. 2018 Nov 6;115(45):E10672-E10681. doi: 10.1073/pnas.1810580115. Epub 2018 Oct 22.
10
TRAIL-Mediated Suppression of T Cell Receptor Signaling Inhibits T Cell Activation and Inflammation in Experimental Autoimmune Encephalomyelitis.TRAIL 介导的 T 细胞受体信号抑制可抑制实验性自身免疫性脑脊髓炎中的 T 细胞激活和炎症。
Front Immunol. 2018 Jan 22;9:15. doi: 10.3389/fimmu.2018.00015. eCollection 2018.